Antibodies and related molecules that bind to 161P2F10B proteins
First Claim
1. A monoclonal antibody or antigen-binding fragment thereof comprising an antigen binding site that binds specifically to 161P2F10B protein comprising the amino acid sequence of SEQ ID NO:
- 4, and wherein the monoclonal antibody comprises the VH region of SEQ ID NO;
145, from residue 20 to 142 and the VL region of SEQ ID NO;
146, from residue 20 to 127.
1 Assignment
0 Petitions
Accused Products
Abstract
Antibodies and molecules derived therefrom that bind to 161P2F10B protein and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization.
-
Citations
20 Claims
-
1. A monoclonal antibody or antigen-binding fragment thereof comprising an antigen binding site that binds specifically to 161P2F10B protein comprising the amino acid sequence of SEQ ID NO:
- 4, and wherein the monoclonal antibody comprises the VH region of SEQ ID NO;
145, from residue 20 to 142 and the VL region of SEQ ID NO;
146, from residue 20 to 127. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
- 4, and wherein the monoclonal antibody comprises the VH region of SEQ ID NO;
Specification